News

The healthcare company's payout currently yields 3.3%, more than double the S&P 500 's ( ^GSPC 0.32%) dividend yield (near a ...
CNBC’s Jim Cramer explained what made shares of Johnson & Johnson rise after the company posted its quarterly report.
Johnson & Johnson (NYSE:JNJ) ranks among the best forever stocks to invest in. Prior to the company’s second-quarter earnings ...
J&J's stock price is down from its 2022 peak, but it's performed better than you might think by simply looking at its chart.
J&J's diversified business, robust pipeline, and strong free cash flow provide stability, despite legal challenges. Read more ...
Johnson & Johnson revised its fiscal year 2025 guidance. The company expects adjusted earnings of $10.80-$10.90, up from ...
The talking point, as of late, stemming from the 2025 NFL Draft, was why second-round picks weren't signing. As of a few days ...